AtriCure (ATRC) EBITDA margin US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | -16.3% | -13.4% | -14.0% | -8.93% | -2.03% | -2.89% | ||
Changes by years, y/y, % | -7pp | +3pp | -1pp | +5pp | +7pp | -13.3% |
AtriCure. EBITDA margin, %
AtriCure. EBITDA margin, changes, pp
AtriCure (ATRC) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA margin, % | ? | -3.18% | -3.23% | -6.39% | -1.39% | -0.81% | -2.89% | |
Changes by years, y/y, % | +10pp | +1pp | 0pp | +3pp | +2pp | |||
Changes by quarters, q/q, % | +1pp | 0pp | -3pp | +5pp | +1pp |